GSK has reached ... 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed to pay $2.2 billion to settle ...

GSK plc (NYSE:GSK) – GSK agreed to pay up to $2.2 billion to settle 93% of U.S. lawsuits related to Zantac, alleging the drug caused cancer. The settlement, announced Wednesday, was lower than ...

GSK last month agreed to settle about 80,000 Zantac lawsuits, representing most of the litigation against it, for $2.2 billion. Pfizer has also agreed to settle most of the outstanding cases ...

This writer takes a look at a beaten down FTSE 100 stock that has been sliding lower. Has it reached his Buy zone yet or is it one to watch? The post Why this falling FTSE 100 stock could be entering ...

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits ... GSK said it did not settle Ms Kasza’s ...

GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

“The jury agreed that Boehringer’s Zantac was dangerous and that they ... was the first from among 5,000 lawsuits in California state courts, all coordinated in Alameda County Superior Court.

Walt Disney Co. has agreed ... long-running lawsuit brought by a group of female employees who alleged gender pay discrimination at the Burbank entertainment giant. The proposed settlement was ...

Walt Disney Co. has agreed to pay $43 million ... for more than a decade. The settlement, which still has to be approved by a judge, stems from a 2019 lawsuit brought by LaRonda Rasmussen, who ...